
No. of Pages: 122 | Report Code: BMIRE00025322 | Category: Life Sciences
No. of Pages: 122 | Report Code: BMIRE00025322 | Category: Life Sciences
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Middle East & Africa Infectious Disease Diagnostics Market, by Geography (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Infectious Disease Diagnostics Market Landscape
4.1 Overview
4.2 Middle East & Africa PEST Analysis
5. Middle East & Africa Infectious Disease Diagnostics Market - Key Industry Dynamics
5.1 Market Drivers:
5.1.1 Rising Incidence of Infectious Diseases
5.1.2 Rising Application of Diagnostics in Veterinary Infectious Disease
5.2 Market Restraints
5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics
5.4 Future Trends
5.4.1 Rising Number of Product Approvals and Launches
5.5 Impact Analysis:
6. Infectious Disease Diagnostics Market - Middle East & Africa Market Analysis
6.1 Middle East & Africa Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 - 2030
7. Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Product
7.1 Overview
7.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%)
7.3 Kits & Reagents
7.3.1 Overview
7.3.2 Kits & Reagents: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Software & Services
7.5.1 Overview
7.5.2 Software & Services: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Technology
8.1 Overview
8.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%)
8.3 Biosensor-based
8.3.1 Overview
8.3.2 Biosensor-based: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Immunodiagnostics
8.4.1 Overview
8.4.2 Immunodiagnostics: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.4.2.1 Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
8.5 Molecular-Based Diagnostic Techniques
8.5.1 Overview
8.5.2 Molecular-Based Diagnostic Techniques: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
8.6 Clinical Biology
8.6.1 Overview
8.6.2 Clinical Biology: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Application Type
9.1 Overview
9.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%)
9.3 Point-of-Care Testing
9.3.1 Overview
9.3.2 Point-of-Care Testing: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Laboratory Testing
9.4.1 Overview
9.4.2 Laboratory Testing: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Testing Type
10.1 Overview
10.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%)
10.3 Human Testing
10.3.1 Overview
10.3.2 Human Testing: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.3.2.1 Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
10.4 Veterinary Testing
10.4.1 Overview
10.4.2 Veterinary Testing: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11. Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by End User
11.1 Overview
11.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%)
11.3 Diagnostic Laboratories
11.3.1 Overview
11.3.2 Diagnostic Laboratories: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.4 Hospitals and Clinics
11.4.1 Overview
11.4.2 Hospitals and Clinics: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.5 Research Institutes
11.5.1 Overview
11.5.2 Research Institutes: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.6 Homecare Settings
11.6.1 Overview
11.6.2 Homecare Settings: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.7 Others
11.7.1 Overview
11.7.2 Others: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
12. Middle East & Africa Infectious Disease Diagnostics Market - Country Analysis
12.1 Middle East & Africa Infectious Disease Diagnostics Market - Country Analysis
12.1.1 Middle East & Africa Infectious Disease Diagnostics Market, by Country
12.1.1.1 Saudi Arabia
12.1.1.1.1 Overview
12.1.1.1.2 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.1.1.3 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
12.1.1.1.4 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
12.1.1.1.4.1 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
12.1.1.1.4.2 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
12.1.1.1.5 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
12.1.1.1.6 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
12.1.1.1.6.1 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
12.1.1.1.7 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
12.1.1.2 South Africa
12.1.1.2.1 Overview
12.1.1.2.2 South Africa: Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.1.2.3 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
12.1.1.2.4 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
12.1.1.2.4.1 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
12.1.1.2.4.2 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
12.1.1.2.5 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
12.1.1.2.6 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
12.1.1.2.6.1 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
12.1.1.2.7 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
12.1.1.3 UAE
12.1.1.3.1 Overview
12.1.1.3.2 UAE: Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.1.3.3 UAE: Middle East & Africa Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
12.1.1.3.4 UAE: Middle East & Africa Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
12.1.1.3.4.1 UAE: Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
12.1.1.3.4.2 UAE: Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
12.1.1.3.5 UAE: Middle East & Africa Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
12.1.1.3.6 UAE: Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
12.1.1.3.6.1 UAE: Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
12.1.1.3.7 UAE: Middle East & Africa Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
12.1.1.4 Rest of Middle East & Africa
12.1.1.4.1 Overview
12.1.1.4.2 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.1.4.3 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
12.1.1.4.4 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
12.1.1.4.4.1 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
12.1.1.4.4.2 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
12.1.1.4.5 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
12.1.1.4.6 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
12.1.1.4.6.1 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
12.1.1.4.7 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 Abbott Laboratories
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Bruker Corp
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Cardinal Health Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 F. Hoffmann-La Roche Ltd
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Trinity Biotech Plc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Danaher Corp
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Bio-Rad Laboratories Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 ACON Laboratories Inc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 DiaSorin SpA
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About Us
15.2 Glossary of Terms
List of Tables
Table 1. Middle East & Africa Infectious Disease Diagnostics Market Segmentation
Table 2. Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 3. Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 4. Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 5. Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 6. Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 7. Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 8. Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 9. Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million)
Table 10. Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 11. Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 12. Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. South Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 15. South Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 16. South Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 17. South Africa Middle East & Africa Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million)
Table 18. South Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 19. South Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 20. South Africa: Middle East & Africa Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 21. UAE: Middle East & Africa Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 22. UAE: Middle East & Africa Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 23. UAE: Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 24. UAE: Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 25. UAE: Middle East & Africa Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million)
Table 26. UAE: Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 27. UAE: Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 28. UAE: Middle East & Africa Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 29. Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 30. Rest of Middle East & Africa: Middle East & Africa a Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 31. Rest of Middle East & Africa Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Middle East & Africa Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 33. Rest of Middle East & Africa Middle East & Africa Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million)
Table 34. Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 35. Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 36. Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 37. Organic Developments Done By Companies
Table 38. Inorganic Developments Done By Companies
Table 39. Glossary of Terms, Middle East & Africa Infectious Disease Diagnostics Market
List of Figures
Figure 1. Middle East & Africa Infectious Disease Diagnostics Market Segmentation, By Country
Figure 2. Middle East & Africa - PEST Analysis
Figure 3. Middle East & Africa Infectious Disease Diagnostics Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Middle East & Africa Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 - 2030
Figure 6. Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%)
Figure 7. Kits & Reagents: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Instruments: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Software & Services: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%)
Figure 11. Biosensor-based: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Immunodiagnostics: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Molecular-Based Diagnostic Techniques: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Clinical Biology: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Others: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%)
Figure 17. Point-of-Care Testing: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Laboratory Testing: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%)
Figure 20. Human Testing: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Veterinary Testing: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 23. Diagnostic Laboratories: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Hospitals and Clinics: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Research Institutes: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Homecare Settings: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Others: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Middle East & Africa Infectious Disease Diagnostics Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 29. Middle East & Africa Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%)
Figure 30. Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. South Africa: Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. UAE: Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 33. Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Growth Strategies Done by the Companies in the Market, (%)
1. Abbott Laboratories
2. Bruker Corp
3. Cardinal Health Inc
4. F. Hoffmann-La Roche Ltd
5. Trinity Biotech Plc
6. Danaher Corp
7. Bio-Rad Laboratories Inc
8. ACON Laboratories Inc
9. DiaSorin SpA